Summary
Further key aspects of the report:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Sleeping Pills (Prescription Drugs) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Sleeping Pills (Prescription Drugs) market segmented into
Zolpidem
Eszopiclone (Lunesta)
Ramelteon (Rozerem)
Ativan (lorazepam)
Adapin (doxepin)
Based on the end-use, the global Sleeping Pills (Prescription Drugs) market classified into
Hospital Pharmacy
Retail Pharmacy
Based on geography, the global Sleeping Pills (Prescription Drugs) market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Sanofi
Abbott Laboratories
Takeda Pharmaceutical
Apotex
Aurobindo Pharma
Actellon Pharmaceuticals
Allegiant Health
Cayman Chemical
Ambitropin
Hayao
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL SLEEPING PILLS (PRESCRIPTION DRUGS) INDUSTRY
2.1 Summary about Sleeping Pills (Prescription Drugs) Industry
2.2 Sleeping Pills (Prescription Drugs) Market Trends
2.2.1 Sleeping Pills (Prescription Drugs) Production & Consumption Trends
2.2.2 Sleeping Pills (Prescription Drugs) Demand Structure Trends
2.3 Sleeping Pills (Prescription Drugs) Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Zolpidem
4.2.2 Eszopiclone (Lunesta)
4.2.3 Ramelteon (Rozerem)
4.2.4 Ativan (lorazepam)
4.2.5 Adapin (doxepin)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital Pharmacy
4.3.2 Retail Pharmacy
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Zolpidem
5.2.2 Eszopiclone (Lunesta)
5.2.3 Ramelteon (Rozerem)
5.2.4 Ativan (lorazepam)
5.2.5 Adapin (doxepin)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital Pharmacy
5.3.2 Retail Pharmacy
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Zolpidem
6.2.2 Eszopiclone (Lunesta)
6.2.3 Ramelteon (Rozerem)
6.2.4 Ativan (lorazepam)
6.2.5 Adapin (doxepin)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital Pharmacy
6.3.2 Retail Pharmacy
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Zolpidem
7.2.2 Eszopiclone (Lunesta)
7.2.3 Ramelteon (Rozerem)
7.2.4 Ativan (lorazepam)
7.2.5 Adapin (doxepin)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital Pharmacy
7.3.2 Retail Pharmacy
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Zolpidem
8.2.2 Eszopiclone (Lunesta)
8.2.3 Ramelteon (Rozerem)
8.2.4 Ativan (lorazepam)
8.2.5 Adapin (doxepin)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital Pharmacy
8.3.2 Retail Pharmacy
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Zolpidem
9.2.2 Eszopiclone (Lunesta)
9.2.3 Ramelteon (Rozerem)
9.2.4 Ativan (lorazepam)
9.2.5 Adapin (doxepin)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital Pharmacy
9.3.2 Retail Pharmacy
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Sanofi
10.1.2 Abbott Laboratories
10.1.3 Takeda Pharmaceutical
10.1.4 Apotex
10.1.5 Aurobindo Pharma
10.1.6 Actellon Pharmaceuticals
10.1.7 Allegiant Health
10.1.8 Cayman Chemical
10.1.9 Ambitropin
10.1.10 Hayao
10.2 Sleeping Pills (Prescription Drugs) Sales Date of Major Players (2017-2020e)
10.2.1 Sanofi
10.2.2 Abbott Laboratories
10.2.3 Takeda Pharmaceutical
10.2.4 Apotex
10.2.5 Aurobindo Pharma
10.2.6 Actellon Pharmaceuticals
10.2.7 Allegiant Health
10.2.8 Cayman Chemical
10.2.9 Ambitropin
10.2.10 Hayao
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Sleeping Pills (Prescription Drugs) Product Type Overview
Table Sleeping Pills (Prescription Drugs) Product Type Market Share List
Table Sleeping Pills (Prescription Drugs) Product Type of Major Players
Table Brief Introduction of Sanofi
Table Brief Introduction of Abbott Laboratories
Table Brief Introduction of Takeda Pharmaceutical
Table Brief Introduction of Apotex
Table Brief Introduction of Aurobindo Pharma
Table Brief Introduction of Actellon Pharmaceuticals
Table Brief Introduction of Allegiant Health
Table Brief Introduction of Cayman Chemical
Table Brief Introduction of Ambitropin
Table Brief Introduction of Hayao
Table Products & Services of Sanofi
Table Products & Services of Abbott Laboratories
Table Products & Services of Takeda Pharmaceutical
Table Products & Services of Apotex
Table Products & Services of Aurobindo Pharma
Table Products & Services of Actellon Pharmaceuticals
Table Products & Services of Allegiant Health
Table Products & Services of Cayman Chemical
Table Products & Services of Ambitropin
Table Products & Services of Hayao
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Sleeping Pills (Prescription Drugs) Market Forecast (Million USD) by Region 2021f-2026f
Table Global Sleeping Pills (Prescription Drugs) Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Sleeping Pills (Prescription Drugs) Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Sleeping Pills (Prescription Drugs) Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Sleeping Pills (Prescription Drugs) Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Sleeping Pills (Prescription Drugs) Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Sleeping Pills (Prescription Drugs) Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Sleeping Pills (Prescription Drugs) Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Sleeping Pills (Prescription Drugs) Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Sleeping Pills (Prescription Drugs) Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Sleeping Pills (Prescription Drugs) Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zolpidem Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Eszopiclone (Lunesta) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ramelteon (Rozerem) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ativan (lorazepam) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adapin (doxepin) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zolpidem Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Eszopiclone (Lunesta) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ramelteon (Rozerem) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ativan (lorazepam) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adapin (doxepin) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zolpidem Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Eszopiclone (Lunesta) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ramelteon (Rozerem) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ativan (lorazepam) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adapin (doxepin) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zolpidem Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Eszopiclone (Lunesta) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ramelteon (Rozerem) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ativan (lorazepam) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adapin (doxepin) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zolpidem Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Eszopiclone (Lunesta) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ramelteon (Rozerem) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ativan (lorazepam) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adapin (doxepin) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zolpidem Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Eszopiclone (Lunesta) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ramelteon (Rozerem) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ativan (lorazepam) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adapin (doxepin) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Sleeping Pills (Prescription Drugs) Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Sleeping Pills (Prescription Drugs) Sales Revenue (Million USD) of Abbott Laboratories 2017-2020e
Figure Sleeping Pills (Prescription Drugs) Sales Revenue (Million USD) of Takeda Pharmaceutical 2017-2020e
Figure Sleeping Pills (Prescription Drugs) Sales Revenue (Million USD) of Apotex 2017-2020e
Figure Sleeping Pills (Prescription Drugs) Sales Revenue (Million USD) of Aurobindo Pharma 2017-2020e
Figure Sleeping Pills (Prescription Drugs) Sales Revenue (Million USD) of Actellon Pharmaceuticals 2017-2020e
Figure Sleeping Pills (Prescription Drugs) Sales Revenue (Million USD) of Allegiant Health 2017-2020e
Figure Sleeping Pills (Prescription Drugs) Sales Revenue (Million USD) of Cayman Chemical 2017-2020e
Figure Sleeping Pills (Prescription Drugs) Sales Revenue (Million USD) of Ambitropin 2017-2020e
Figure Sleeping Pills (Prescription Drugs) Sales Revenue (Million USD) of Hayao 2017-2020e